CTHRC1 and thyroid cancer: Therefore, the BRAF(V600E) mutation was associated with CTHRC1 expression, and both were correlated with immune cell infiltration including CD4+ T cells, CD8+ T cells, and neutrophils, in colon cancer and thyroid cancer patients.